Koninklijke Vopak NV
F:VPK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Koninklijke Vopak NV
F:VPK
|
NL |
|
H
|
Health Empire Corporation PCL
SET:HEMP
|
TH |
|
Basilea Pharmaceutica AG
SIX:BSLN
|
CH |
|
Versus Systems Inc
NASDAQ:VS
|
CA |
|
F
|
Fuxing China Group Ltd
SGX:AWK
|
CN |
|
Asics Corp
TSE:7936
|
JP |
Wall St Price Targets
VPK Price Targets Summary
Koninklijke Vopak NV
According to Wall Street analysts, the average 1-year price target for VPK is 53.84 EUR with a low forecast of 43.64 EUR and a high forecast of 65.25 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is VPK's stock price target?
Price Target
53.84
EUR
According to Wall Street analysts, the average 1-year price target for VPK is 53.84 EUR with a low forecast of 43.64 EUR and a high forecast of 65.25 EUR.
What is the Revenue forecast for Koninklijke Vopak NV?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Revenue has been 0%. The projected CAGR for the next 3 years is 3%.
What is the Operating Income forecast for Koninklijke Vopak NV?
Projected CAGR
22%
Over the last 13 years, the compound annual growth rate for Operating Income has been -2%. The projected CAGR for the next 3 years is 22%.
What is the Pre-Tax Income forecast for Koninklijke Vopak NV?
Projected CAGR
-12%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 3%. The projected CAGR for the next 3 years is -12%.
What is the Net Income forecast for Koninklijke Vopak NV?
Projected CAGR
-6%
Over the last 13 years, the compound annual growth rate for Net Income has been 5%. The projected CAGR for the next 3 years is -6%.
